Investing

Curis : CRIS

CRIS

Stock Data

$4.02

$0.39 (8.84%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. The company is headquartered in Lexington, Massachusetts.

All Curis Articles

3 Articles

Lee Jackson | Mar 25, 2021 at 8:48 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Cisco, eHealth, iHeart Media, Intel, Playtika, ViacomCBS, Williams-Sonoma and More

Thursday's top analyst upgrades and downgrades included AllianceBernstein, AMD, Cisco, eHealth, iHeart Media, Intel, Playtika, ViacomCBS and Williams-Sonoma.

Chris Lange | Dec 9, 2020 at 9:53 AM EST

The Hits Keep Coming With Curis’s Secondary Offering

Curis shares are on the run again. This time it’s due to a secondary offering.

Chris Lange | Dec 8, 2020 at 9:56 AM EST

This Curis Cancer Study Is a Big Hit

Curis has announced preliminary data from its ongoing early-stage study in patients with acute myeloid leukemia or high-risk myelodysplastic syndromes.